Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KT182 is a selective and potent inhibitor of α/β-hydrolase domain containing 6 (ABHD6), with an IC50 of 0.24 nM in Neuro2A cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 64.00 | |
5 mg | In stock | $ 155.00 | |
10 mg | In stock | $ 239.00 | |
25 mg | In stock | $ 395.00 | |
50 mg | In stock | $ 589.00 | |
100 mg | In stock | $ 842.00 | |
500 mg | In stock | $ 1,680.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 169.00 |
Description | KT182 is a selective and potent inhibitor of α/β-hydrolase domain containing 6 (ABHD6), with an IC50 of 0.24 nM in Neuro2A cells. |
Targets&IC50 | ABHD6 in Neuro2A cells:0.24 nM |
In vivo | KT182 (i.p, 1mg/kg, 4 hours) complete blockade of ABHD6 in the mice liver[1]. |
Molecular Weight | 438.52 |
Formula | C27H26N4O2 |
CAS No. | 1402612-62-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90mg/mL (205.2mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KT182 1402612-62-7 Metabolism MAGL KT-182 KT 182 inhibitor inhibit